JPS59196084A - Device for treating blood - Google Patents

Device for treating blood

Info

Publication number
JPS59196084A
JPS59196084A JP58070017A JP7001783A JPS59196084A JP S59196084 A JPS59196084 A JP S59196084A JP 58070017 A JP58070017 A JP 58070017A JP 7001783 A JP7001783 A JP 7001783A JP S59196084 A JPS59196084 A JP S59196084A
Authority
JP
Japan
Prior art keywords
blood
bacteria
container
filter
processing device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58070017A
Other languages
Japanese (ja)
Other versions
JPS6233872B2 (en
Inventor
Satoshi Kaminagayoshi
上永吉 敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP58070017A priority Critical patent/JPS59196084A/en
Priority to DE8484103965T priority patent/DE3483914D1/en
Priority to EP84103965A priority patent/EP0122581B1/en
Publication of JPS59196084A publication Critical patent/JPS59196084A/en
Publication of JPS6233872B2 publication Critical patent/JPS6233872B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02Separating microorganisms from the culture medium; Concentration of biomass

Abstract

PURPOSE:A device containing a solution having both a hemolysis agent and an anticoagulant, keeping a rubber stopper communicated with blood-containing space, being sterilized, capable of blending the blood with the solution, etc. sufficiently in a closed system. CONSTITUTION:The mixed solution 2 having a hemolysis agent, an anticoagulant, and, if necessary, a liquid medium, is contained in the container 1, the rubber stopper 3 is detachably attached to the opening of the container 1, and the container is hermetically sealed. The interior of the container 1 is kept at reduced pressure, so that collected blood is easily introduced into the container 1. The device for treating blood is sterilized in order to prevent the collected blood being infected with them.

Description

【発明の詳細な説明】 ■1発明の背景 技術分野 本発明は、血液中の細菌を分離し培養するのに使用され
る新規な血液処理器に関するものである。
DETAILED DESCRIPTION OF THE INVENTION (1) Background of the Invention Technical Field The present invention relates to a novel blood processing device used for separating and culturing bacteria in blood.

敗血症や菌血症等重篤な全身感染症においては患者の血
液中に細菌が存在しているのでこれら感染症の診断に(
4血液の細菌検査が行なわれる。また抗菌剤の動物試験
による薬効判定においても血液の細菌検査が行なわれる
。これらの細菌検査には先ず検体血液から細菌を培養お
よび分離することが必要であり、次いで薬剤感受性試験
や菌の同定等が行なわれる。本発明の器具はこのような
細菌検査の際の検体処理に使用される。
In serious systemic infections such as sepsis and bacteremia, bacteria are present in the patient's blood, so when diagnosing these infections,
4 A blood bacteriological test is performed. Bacteria testing of blood is also carried out to determine the efficacy of antibacterial agents through animal testing. In these bacterial tests, it is first necessary to culture and isolate bacteria from sample blood, and then drug susceptibility tests and bacterial identification are performed. The instrument of the present invention is used for specimen processing during such bacterial testing.

(先行技術および問題点) 従来、血中細菌の培養訃よび分離は、採取した血液を液
体栄養培地と混合して培地増殖した菌で濁るまで培養し
、次に増殖した菌を血液寒天平板、チョコレート寒天平
板等の培地上に移植してさらに培養することによってコ
ロニ育成が行なわれている。
(Prior Art and Problems) Conventionally, in the culture and isolation of blood bacteria, collected blood is mixed with a liquid nutrient medium and cultured until the medium becomes cloudy with bacteria grown in the medium, and then the grown bacteria are cultured on a blood agar plate. Colonies are grown by transplanting them onto a medium such as a chocolate agar plate and culturing them further.

このように従来法においては血液から少ない細菌を直接
分離して培養することが困難であシ、コロニーを育成す
る前処理として増菌培養という伺加的操作で菌数を増す
ことを必要とするため繁雑な操作と長時間を要している
。特に上記のような液体中での増菌培養は一般に長時間
を要する。また血液はそれ自体菌の増殖を抑制する作用
を有し、抗菌剤が膜力されている場合には血液中での菌
の増殖は一層困難であり、検体中の細菌数が少ない場合
には検出不可能な場合もある。さらに、菌を増殖培地か
ら分ト1「培地へ移植する際、検査菌が環境を汚染した
9あるいは雑菌が検査菌に混入したシして検査精度を低
下させるおそれがある。
In this way, with conventional methods, it is difficult to directly isolate and culture small numbers of bacteria from blood, and it is necessary to increase the number of bacteria through an additional operation called enrichment culture as a pretreatment for cultivating colonies. This requires complicated operations and a long time. In particular, enrichment culture in a liquid as described above generally requires a long time. In addition, blood itself has the effect of inhibiting the growth of bacteria, and when antibacterial agents are used as a membrane, it is even more difficult for bacteria to grow in the blood, and when the number of bacteria in the sample is small, Sometimes it is undetectable. Furthermore, when the bacteria are transferred from the growth medium to the culture medium, there is a risk that the test bacteria may contaminate the environment or contaminate the test bacteria, reducing the accuracy of the test.

■1発明の目的 そこで本発明者等は鋭意研究を重ねた結果、細菌浪人血
液をすくなくとも溶血剤および抗血液凝固剤からなる溶
液あるいは溶血剤、抗血液凝固剤および液体培地からな
る溶液と混合し、前記混合物を細菌を通さない大きさの
孔を有するフィルタと前記フィルタの裏面に接着された
吸水体あるいは液体培地を含浸乾燥させた吸水体とを前
記フィルタを上にして容器に収容してなるろ過培養器で
ろ過し、ろ過されたフィルタ上の細菌をその−1ま培養
することにより血中細菌を分離培養する方法を開発した
■1 Purpose of the Invention Therefore, as a result of extensive research, the inventors of the present invention have found that bacterial ronin blood is mixed with a solution consisting of at least a hemolytic agent and an anticoagulant, or a solution consisting of a hemolytic agent, an anticoagulant, and a liquid medium. , a filter having pores large enough to prevent bacteria from passing through the mixture, and a water absorbent adhered to the back surface of the filter or a water absorbent impregnated with a liquid medium and dried, are housed in a container with the filter facing upward. We have developed a method for isolating and culturing bacteria in the blood by filtering it with a filtration incubator and culturing the bacteria on the filter to -1.

この培養法によれば、血中細菌を増菌培養する等の前処
理操作を必要とせず直接血液中の細菌を集め、他の培地
に移植することなくその寸ま培養することが可能である
。而してこの培養法においては、採血した血液を溶血剤
および抗血液凝固剤からなる溶液あるいは溶血剤、抗凝
固剤および液体培地からなる溶液と十分に混和する操作
が必須であシ、この操作は、検査菌による環境汚染およ
び検体の汚染を防止するため、密閉容器中で行うことが
要求される。
According to this culture method, it is possible to directly collect blood bacteria without the need for pretreatment operations such as enrichment culture of blood bacteria, and to culture them to that extent without transplanting them to another medium. . Therefore, in this culture method, it is essential to thoroughly mix the collected blood with a solution consisting of a hemolytic agent and an anticoagulant, or a solution consisting of a hemolytic agent, an anticoagulant, and a liquid medium. must be carried out in a closed container to prevent environmental contamination and specimen contamination by test bacteria.

従って発明の目的は、血液をすくなくとも溶血剤および
抗血液凝固剤からなる溶液あるいは溶血剤、抗凝固剤お
よび液体培地からなる溶液を密閉系で混和することを可
能とする器具を提供するととにある。
Accordingly, an object of the invention is to provide an instrument that allows mixing a solution consisting of a hemolytic agent and an anticoagulant or a solution consisting of a hemolytic agent, an anticoagulant, and a liquid medium in a closed system, at least by aliquoting blood. .

しかして上記の目的は以下に示す本発明の器具によって
達成される。
The above objects are thus achieved by the device of the invention as described below.

(1)′t<なくとも溶血剤および抗血液凝固剤を含む
溶液を収容し、かっ血液収容空間を有する容滅菌処理さ
れていることを特徴とする血液処理器。  − (2)  世吻溶液が喰≠培地を含んでいる第1項記載
の血液処理器。
(1) A blood processing device that is sterilized and contains a solution containing at least a hemolytic agent and an anticoagulant, and has a blood storage space. - (2) The blood processing device according to item 1, wherein the blood treatment solution contains food≠medium.

(3)血液収容空間が減圧にされている第1項一または
第2項記載の血液処理器。
(3) The blood processing device according to item 1 or 2, wherein the blood storage space is under reduced pressure.

(4)上記容器が筒状体と、該筒状体の内壁を液密に摺
動できるように配置した押子とからなる第1項または第
2項記載の血液処理器。
(4) The blood processing device according to item 1 or 2, wherein the container comprises a cylindrical body and a pusher arranged to slide on the inner wall of the cylindrical body in a liquid-tight manner.

上記の構造を有する本発明の血液処理器を使用すること
によシ、血液は、溶血剤」?よび抗血液凝固剤からなる
溶液あるいは、溶血剤、抗血液凝固剤および液体培地か
らなる溶液と密閉系で十分混和することができ、血液中
の細菌が環境を汚染したシ、外部の雑菌が血液検体中に
混入したシするおそれがない。
By using the blood processing device of the present invention having the above structure, the blood can be treated as a hemolytic agent. It can be sufficiently mixed with a solution consisting of a hemolytic agent, an anticoagulant, or a solution consisting of a hemolytic agent, an anticoagulant, and a liquid medium in a closed system. There is no risk of contamination in the sample.

■0発明の詳細な説明 以下本発明の構成を図面に示す実施例に基づいて詳細に
説明する。
(2) Detailed Description of the Invention The configuration of the present invention will be described in detail below based on embodiments shown in the drawings.

第1図に本発明の血液処理器の一実施例を示す。FIG. 1 shows an embodiment of the blood processing device of the present invention.

この血液処理器はすくなくとも溶血剤および抗血液凝固
剤の混合溶液2を収容した容器1と前記容器1の開口部
に着脱可能でかつ密封可能に嵌着されたゴム栓3とから
な9容器1の内部は減圧に保たれている。この血液処理
器を用いて血液を処理するには、採血した注射器(図示
省略)の針をゴム栓3を貫通するように突き刺し、容器
1内の減圧を利用して血液を容器1内に導入し、血液導
入完了後針を抜き、容器を転倒させて血液を容器内の溶
液と混和させる。溶血剤としてはサポニンが好適に使用
され、抗血液凝固剤としてはアミロ硫酸ナトリウム、ポ
リアネトールfA 酸ナトリウム等が好適に使用される
。これらの混合溶液には所望によシ液体培地を混合する
こともできる。この場合には次の操作で使用する分離培
養器の吸水体に培地を含浸させる必要がない。また、菌
の増殖が早くなる。
This blood processing device consists of a container 1 containing at least a mixed solution 2 of a hemolytic agent and an anticoagulant, and a rubber stopper 3 removably and sealably fitted into the opening of the container 1. The interior of the is maintained at reduced pressure. To process blood using this blood processing device, the needle of a syringe (not shown) used to collect blood is pierced through the rubber stopper 3, and the blood is introduced into the container 1 using the reduced pressure inside the container 1. After the blood has been introduced, the needle is removed and the container is inverted to mix the blood with the solution in the container. Saponin is preferably used as the hemolytic agent, and sodium amylosulfate, sodium polyanethole fA acid, etc. are preferably used as the anticoagulant. A liquid medium can also be mixed with these mixed solutions, if desired. In this case, there is no need to impregnate the water absorbing body of the separation culture vessel with the medium to be used in the next operation. Also, bacteria multiply faster.

第2図は本発明の血液処理器の他の実施例を示す。この
血液処理器は筒状体4と該筒状体の内壁を液密に摺動で
きるように配置した押子5からな9、筒状体4の開口部
に1はゴム栓3が着脱可能でかつ密封可能に吐着され、
筒状体4と押子5で形成される空間に先の実施例と同様
の溶血剤および抗血液凝固剤からなる混合液2が収容さ
れている。
FIG. 2 shows another embodiment of the blood processing device of the present invention. This blood processing device consists of a cylindrical body 4 and a pusher 5 arranged to slide on the inner wall of the cylindrical body in a liquid-tight manner.A rubber plug 3 is removably attached to the opening of the cylindrical body 4. Discharged in a large and sealable manner,
A mixed liquid 2 consisting of a hemolytic agent and an anticoagulant similar to that of the previous embodiment is contained in the space formed by the cylindrical body 4 and the pusher 5.

この混合液も液体培地が混合してあってもよいこの血液
処理器を用いて血液を処理するに1d1採血した注射器
の針をゴム栓3を貫通するように突き刺し、注射器で血
液を圧入すると血液処理器の押子5が下方へ摺動しなが
ら血液が容83内に導入される。血液の導入完了後、容
器を転倒し血液を溶血剤および抗血液凝固剤と十分混和
する。これら血液処理器は検体血液に雑菌が混入するの
を防ぐために、γ線照射またはオートクレーブにより滅
菌されている。
This mixed solution may also be mixed with a liquid medium. To process blood using this blood processing device, insert the needle of a syringe that has collected 1d1 blood through the rubber stopper 3, and press the blood into the syringe. Blood is introduced into the container 83 while the pusher 5 of the processor slides downward. After the blood has been introduced, the container is inverted to thoroughly mix the blood with the hemolytic agent and anticoagulant. These blood processing devices are sterilized by γ-ray irradiation or autoclaving to prevent contamination of sample blood with bacteria.

本発明の血液処理器で血液を処理することにより赤血球
の破壊と血液凝固の防止が行なわれる。
By treating blood with the blood processor of the present invention, red blood cells are destroyed and blood coagulation is prevented.

これらの操作は、次の血液ろ過操作および血液細菌の培
養を円滑に行うために不可欠でちる。また、液体培地が
混入されている場合には混合処理も同時にできる。
These operations are essential for the subsequent blood filtration operation and culture of blood bacteria to be performed smoothly. In addition, if a liquid medium is mixed, a mixing process can be performed at the same time.

本発明の血液処理器で血液を処理した後ゴム栓をはずし
、次に示す分離培養器のフィルタ上に検体血液を注ぐ。
After treating the blood with the blood processor of the present invention, the rubber stopper is removed, and the sample blood is poured onto the filter of the separation incubator shown below.

ろ過培養器は第3図に示す如く、細菌を通さない大きさ
の孔を有するフィルタ6とフィルタ6の裏面に接着され
た吸水体7とをフィルタ6側を上にして収容した容器本
体8と容器本体8の開口部を着脱自在に被う蓋9とから
なる。
As shown in FIG. 3, the filtration incubator consists of a container body 8 containing a filter 6 having holes large enough to prevent bacteria from passing through, and a water absorbent 7 bonded to the back side of the filter 6 with the filter 6 side up. It consists of a lid 9 that removably covers the opening of the container body 8.

容器本体8はフィルタ6、容器本体側壁10および蓋9
により画成される空間11ならびに吸水体7、容器本体
側壁10および容器本体底12によシ画成される空間1
3を有し、吸水体7より下方に通気孔14が設けられて
いる。
The container body 8 includes a filter 6, a container body side wall 10, and a lid 9.
and a space 1 defined by the water absorbent body 7, the container body side wall 10, and the container body bottom 12.
3, and a ventilation hole 14 is provided below the water absorbent body 7.

フィールター6−は血中細菌をろ過するためのものであ
って細菌を通さない大きさの孔を有する。フィルタ6の
孔の大きさは0.75ミクロン以下好ましくは0.45
ミクロン程度である。フィルタ6の材質は血液に対して
不活性であれば特に制限はないが、代表例としてニトロ
セルロース、ポリカーボネート、ポリアミド、セルロー
スエステルなトラあげることができ、市販のものとして
はミリデア(ミリポラコーポレーション製品)、メトリ
セル(ケ8ルマンインストルノントカンパニー製品)す
どがあげられる。フィルタ6は血液がなじみやすいよう
(・てそれ自体公知の方法によって親水処理されている
のが望ましい。
The filter 6- is for filtering bacteria in the blood and has holes large enough to prevent bacteria from passing through. The pore size of the filter 6 is 0.75 microns or less, preferably 0.45 microns.
It is on the order of microns. The material of the filter 6 is not particularly limited as long as it is inert to blood, but representative examples include nitrocellulose, polycarbonate, polyamide, and cellulose ester.Commercially available materials include Millidea (product of Millipora Corporation). ) and Metricel (a product of Kelman Instrument Company). The filter 6 is desirably treated to be hydrophilic by a method known per se so that blood can easily absorb it.

吸水体7ば、フィルタ6でろ過されたろ過血液を吸収保
持し、ノイルクロ上に捕捉された細菌に栄養を提供する
だめのものである。吸水体7はろ液をほぼ全量吸収する
能力をもつことが望ましい。
The water absorbing body 7 absorbs and retains the filtered blood filtered through the filter 6, and provides nutrients to the bacteria captured on the Noilcro. It is desirable that the water absorbent body 7 has the ability to absorb almost the entire amount of filtrate.

その利質としてはセルロース系のろ紙、不織布等が適当
である。吸水体7はフィルタ6の裏面に接着剤等により
密に密着固定されていることが必要であり、密着歴が不
十分な場合はろ過が円滑に行なわれず、またろ過後吸水
体7からフィルタ6上の細菌への栄養補給が十分性なわ
れない。
Suitable materials include cellulose filter paper and nonwoven fabric. It is necessary that the water absorbent body 7 is closely fixed to the back surface of the filter 6 with an adhesive or the like, and if the adhesion is insufficient, filtration will not be performed smoothly, and the water absorbent body 7 will be tightly fixed to the back surface of the filter 6 after filtration. Nutritional supply to the bacteria on top is not sufficient.

使用される接着剤としてはろ過を阻害しない低融点重合
体繊維による熱シールが好適である。吸水体7には所望
により液体培地を含浸乾燥させておくこともできる。こ
の場合には乾燥培地は吸水体7に吸収保持されるる液に
溶解し、フィルタ6上の細菌に栄養と水分を提供する。
As the adhesive used, heat sealing using low melting point polymer fibers that does not inhibit filtration is preferred. The water absorbent body 7 can also be impregnated with a liquid medium and dried if desired. In this case, the dry medium is dissolved in the liquid absorbed and retained by the water absorbent body 7, and provides nutrients and moisture to the bacteria on the filter 6.

一体化されたフィルタ6と吸水体7は容器本体壁10に
対し隙間なく嵌めこまれ固定されてお9、検体血液がフ
ィルタ6を透過せずに漏れ落ちるのを防いでいる。
The integrated filter 6 and water absorbent body 7 are fitted and fixed to the container body wall 10 without any gaps 9, thereby preventing sample blood from leaking out without passing through the filter 6.

フィルタ6および吸水体7の容器本体壁への固定には接
着剤を用いるかまたは図に示すようにかしめ具15によ
り圧着する。この場合には容器本体8の側壁10部分に
段部Sを形成し、この段部Sに一体化されたフィルタ6
と吸水体7を載置してからかしめ具15を圧入すればよ
い。フィルタ6の上方の空間11は検体血液を貯留する
ためのものであり、吸水体7の下方の空間13は吸水体
7に吸収しきれなかったろ液を受けるためのものである
。通気口14ばろ液により圧迫された空間13内の空気
を排出するためのものであシ、容器本体壁10または容
器本体底12に大気と連通ずるように設けられる。この
通気口14の存在によυ検体血液全量が速やかに自然ろ
過される。通気口14には雑菌の侵入を防止するために
細菌フィルタ16、例えば綿栓を嵌着するのが望ましい
。通気口14が容器本体底部12に設けられるときは、
貯留するろ液が通気口14から流出するのを防ぐため通
気口14のまわシに障壁17が設けられる。また容器本
体底部12全体に障壁を同心円状に設け、ろ液が通気口
14の周辺に集まるのを防止するのが望ましい。
The filter 6 and the water absorbent body 7 are fixed to the wall of the container body using an adhesive or by crimping with a caulking tool 15 as shown in the figure. In this case, a step S is formed on the side wall 10 of the container body 8, and a filter 6 integrated with this step S is formed.
After placing the water absorbent body 7, the caulking tool 15 may be press-fitted. A space 11 above the filter 6 is for storing sample blood, and a space 13 below the water absorbent body 7 is for receiving filtrate that has not been completely absorbed by the water absorbent body 7. The vent hole 14 is for discharging the air in the space 13 compressed by the filtrate, and is provided in the container body wall 10 or the container body bottom 12 so as to communicate with the atmosphere. Due to the presence of this vent 14, the entire amount of sample blood is quickly naturally filtered. It is desirable to fit a bacterial filter 16, such as a cotton plug, into the vent hole 14 to prevent the intrusion of germs. When the vent hole 14 is provided in the bottom part 12 of the container body,
A barrier 17 is provided around the vent 14 to prevent the stored filtrate from flowing out from the vent 14. It is also desirable to provide concentric barriers throughout the bottom 12 of the container body to prevent filtrate from collecting around the vent 14.

以上の構成を有する血中細菌分離培養法器はγ線照射ま
たはエチレンオキサイドガスによる滅菌処理を行ない検
査の信頼性を向上させる。
The blood bacteria isolation and culture device having the above configuration improves the reliability of the test by performing sterilization treatment using gamma ray irradiation or ethylene oxide gas.

このように構成される分離培養器の形状は特に限定され
ないが、一般に円形にするのが望ましい。
The shape of the separation culture vessel constructed in this way is not particularly limited, but it is generally desirable to have a circular shape.

そのサイズも特に限定されることはないが例えば検体と
して血液2ゴを使用する場合、これに適合させるために
は容器本体の直径約60.、程度にするのがよい。
The size of the container is not particularly limited, but for example, when using two samples of blood as a specimen, the diameter of the container body must be approximately 60 mm to accommodate this. , it is better to keep it to a certain extent.

かくして本発明の血液処理器で処理された血液検体を上
記の分離培養器のフィルタ6上に注ぎ蓋9で開放口を被
う。血液は自重で自然ろ過される。
The blood sample thus treated with the blood processing device of the present invention is poured onto the filter 6 of the separation culture device described above, and the open opening is covered with the lid 9. Blood is naturally filtered by its own weight.

血中細菌はフィルタ6上に残シ、血液はフィルタ6を透
過して吸水体7に吸収され、飽和量以上の血液は滴下し
て容器本体底部12に溜まる。ろ液により圧迫された空
気は通気口14から排出されるので、ろ過は検体血液の
自重で円滑に行なわれる。ろ過終了後、該分離培養器を
恒温に保持することによりフィルタ6上に細菌のコロニ
ーが形成される。該コロニーから細菌を採取して細菌の
同定1、薬剤感受性試験等の細菌検査が行なわれる。
Bacteria in the blood remain on the filter 6, blood passes through the filter 6 and is absorbed by the water absorbent 7, and blood in excess of the saturated amount drips and accumulates at the bottom 12 of the container body. Since the air compressed by the filtrate is discharged from the vent 14, filtration is smoothly performed by the weight of the sample blood. After the filtration is completed, bacterial colonies are formed on the filter 6 by maintaining the separation incubator at a constant temperature. Bacteria are collected from the colony and subjected to bacterial tests such as bacterial identification 1 and drug susceptibility testing.

尚吸水体7に液体培地が含浸乾燥させである場合には、
血液の処理操作において、液体培地を加えることは不要
となる。
In addition, when the water absorbent body 7 is impregnated with a liquid medium and dried,
In blood processing operations, it is not necessary to add a liquid medium.

■、発明の具体的作用効果 本発明の血液処理器によれば血液不釦体を密封状態で溶
血・塔凝固処理することができる。従って血中細菌によ
る環境汚染を防止することができ、1だ、検体中に外部
から雑菌が混入するのを防止できるので検査の信頼度を
高めることができる。
(2) Specific Effects of the Invention According to the blood processing device of the present invention, it is possible to hemolyze and coagulate blood in a sealed state. Therefore, it is possible to prevent environmental contamination due to blood bacteria, and 1) it is possible to prevent contamination of external bacteria into the specimen, thereby increasing the reliability of the test.

さらに、本発明の血液処理器を使用することにより、溶
血および抗凝固さらに培地との混合操作が簡素化される
とともに処理後の培養器への移植に伴なう検査菌による
環境汚染および検査菌への雑菌の混入も最小限となる。
Furthermore, by using the blood processing device of the present invention, hemolysis, anticoagulation, and mixing operations with culture media can be simplified, and environmental contamination caused by test bacteria caused by transplantation into an incubator after treatment can be reduced. Contamination with bacteria is also minimized.

さらに、本発明の血液処理器を使用することにより、採
取された検体血液中の全i朋菌が、そのまま分離培養さ
れるので7朋菌の検出率が高く、検体中の菌数を測定す
ることも可能である。
Furthermore, by using the blood processing device of the present invention, all the I-homococcal bacteria in the collected sample blood are isolated and cultured as they are, so the detection rate of the 7-homococcal bacteria is high, and the number of bacteria in the sample can be measured. It is also possible.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の血液処理器の一実施例を示す断1m図
であり、第2図は他の実施例の断面図である。第3図は
、本発明の血液処理器とともに血中細菌分離培養法にお
いて使用される血中ル用菌分離培養器の断面図である。 1・・容器、2・・・溶血剤訃よび抗凝固剤の混合溶液
、3・・コゞム栓、4・・・筒状体、5・・・押子、6
・・フィルタ、7・・・吸水体、8・・・容器本体、9
・・・蓋、14・・・通気口
FIG. 1 is a 1-meter cross-sectional view showing one embodiment of the blood processing device of the present invention, and FIG. 2 is a cross-sectional view of another embodiment. FIG. 3 is a sectional view of a blood bacteria isolation and culturing device used in a blood bacteria isolation and culturing method together with the blood processing device of the present invention. 1... Container, 2... Mixed solution of hemolytic agent and anticoagulant, 3... Column stopper, 4... Cylindrical body, 5... Pusher, 6
... Filter, 7 ... Water absorbing body, 8 ... Container body, 9
...Lid, 14...Vent

Claims (4)

【特許請求の範囲】[Claims] (1)すくなくとも溶血剤および抗血液凝固剤を含む溶
液を収容し、かっ血液収容空間を有すを有し滅菌処理さ
れていることを特徴とする血液処理器。
(1) A blood processing device that contains a solution containing at least a hemolytic agent and an anticoagulant, has a blood storage space, and is sterilized.
(2)会合溶液が→≠培地を含んでいることを特徴とす
る特許請求の範囲第1項記載の血液処理器。
(2) The blood processing device according to claim 1, wherein the association solution contains →≠medium.
(3)血液収容空間が減圧されている特許請求の範囲第
1項または第2項記載の血液処理器。
(3) The blood processing device according to claim 1 or 2, wherein the blood storage space is under reduced pressure.
(4)容器が筒状体と、前記筒状体の内壁を液密に摺動
できるように配置した押子とからなる特許請求の範囲第
1項または第2項記載の血液処理器。
(4) The blood processing device according to claim 1 or 2, wherein the container comprises a cylindrical body and a pusher arranged so as to slide on the inner wall of the cylindrical body in a fluid-tight manner.
JP58070017A 1983-04-15 1983-04-22 Device for treating blood Granted JPS59196084A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58070017A JPS59196084A (en) 1983-04-22 1983-04-22 Device for treating blood
DE8484103965T DE3483914D1 (en) 1983-04-15 1984-04-09 METHOD FOR SEPARATING BACTERIA FROM BLOOD.
EP84103965A EP0122581B1 (en) 1983-04-15 1984-04-09 Process for isolating bacteria in blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58070017A JPS59196084A (en) 1983-04-22 1983-04-22 Device for treating blood

Publications (2)

Publication Number Publication Date
JPS59196084A true JPS59196084A (en) 1984-11-07
JPS6233872B2 JPS6233872B2 (en) 1987-07-23

Family

ID=13419417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58070017A Granted JPS59196084A (en) 1983-04-15 1983-04-22 Device for treating blood

Country Status (1)

Country Link
JP (1) JPS59196084A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007140963A1 (en) * 2006-06-06 2007-12-13 Roche Diagnostics Gmbh Ready-to-use whole blood collection vessel
JP2018520691A (en) * 2015-07-29 2018-08-02 ヴェストファーレン ヴィルヘルム−ウニヴェルジテート ミュンスター Apparatus and method for treating liquids, especially body fluids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5743238A (en) * 1980-08-28 1982-03-11 Fujitsu Ltd Microprocessor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5743238A (en) * 1980-08-28 1982-03-11 Fujitsu Ltd Microprocessor

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007140963A1 (en) * 2006-06-06 2007-12-13 Roche Diagnostics Gmbh Ready-to-use whole blood collection vessel
JP2009540276A (en) * 2006-06-06 2009-11-19 エフ.ホフマン−ラ ロシュ アーゲー Ready-to-use whole blood collection container
US7863040B2 (en) 2006-06-06 2011-01-04 Roche Diagnostics Operations, Inc. Ready-to-use whole blood collection vessel
JP2018520691A (en) * 2015-07-29 2018-08-02 ヴェストファーレン ヴィルヘルム−ウニヴェルジテート ミュンスター Apparatus and method for treating liquids, especially body fluids

Also Published As

Publication number Publication date
JPS6233872B2 (en) 1987-07-23

Similar Documents

Publication Publication Date Title
EP0535212B1 (en) Liquid specimen container and attachable testing modules
EP0122581B1 (en) Process for isolating bacteria in blood
US5301685A (en) Method and apparatus for obtaining a cytology monolayer
US4886071A (en) Package including syringe and needle
JPS6233871B2 (en)
Cheer et al. Improved methods for ATP analysis
CN108138108B (en) Device and method for dispensing liquids, in particular body fluids
JP4047391B2 (en) Micropathological patient replica based on whole blood without impurities
US5667985A (en) Tissue biopsy cell suspender for cell analysis
KR20020097140A (en) Biological fluid processing
JPH0551276B2 (en)
JPS59196084A (en) Device for treating blood
JPH06113817A (en) Determination unit for drug-resistant staphylococcus
JPH0555105B2 (en)
WO1991018085A1 (en) Multi-nutrient growth culturing system and a method of use
JPH02117381A (en) Bacteria separation-culture equipment
JPS59196085A (en) Device for separating and cultivating bacterium in blood
JPS6248374A (en) Tool for clinical test
JPS59106289A (en) Multi-layered tool and device for inspecting culture of microorganism
JP2000262271A (en) Culture unit
JPH0436640Y2 (en)
MXPA99008623A (en) Micropathological patient replica based on unadulterated whole blood